Fig 1_SMG Group overview Aug 2021

Sing Medical – Trades at a 13-month low price despite posting record 1HFY21 results (3 Feb 22)

Dear all On 29 Dec 2020, I have published a write-up on Sing Medical (“SMG”) where I outlined that the risk reward on SMG seems favourable at $0.315, given a potential share transaction scenario (click HERE). Since 29 Dec, SMG rose approximately 32% to trade $0.415 – 0.420 on several occasions in Feb 2021. Subsequently, it dropped sharply in Apr 2021 when it announced that the potential share transaction has lapsed. Fast forward to 31 Jan 2022 and SMG closed at a 13-month low at $0.290. This is notwithstanding its sterling record 1HFY21 results announced in Aug last year where […]

Analyst 11 Sep 20

Riverstone – Is the recent 32% decline justified? (12 Sep 2020)

Riverstone recently caught my attention. It has tumbled approximately 32% from an intraday high of $4.90 on 7 Aug 2020 to close $3.33 on 11 Sep 2020. One client even thought that Riverstone has already undergone a bonus issue! The recent weakness is likely attributed to its co-founder selling 15.5m shares at $3.95 (Bloomberg cites a 90-day lockup on seller); the possibility of a vaccine resulting in demand for gloves and consequently their average selling price (“ASP”) falling off the cliff and some Malaysia investors selling shares to raise cash, as their moratorium on loan repayment ends (click HERE for […]

GSS chart dated 21 Dec 17

GSS announces oil, price drops to near pre announcement! (21 Dec 17)

GSS Energy (“GSS”) announced that it has struck oil and (surprise) gas in its first well on 13 Dec 2017. Share price jumped to an intraday high of S$0.178 on 14 Dec 2017, after the trading halt was lifted. It has since weakened to an intra-day low of S$0.156 on 21 Dec 2017 before closing at $0.161. Is the party in GSS over? Or is this just the beginning? I have managed to meet Mr Sydney Yeung, GSS’ CEO for a 1-1 chat two days ago on the company’s business and outlook.   Here are the key takeaways Q1. Previously, […]